MARSHALL WACE, LLP - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,185,429
+257.2%
713,638
+688.3%
0.02%
+325.0%
Q2 2023$2,291,264
+105.5%
90,528
+119.4%
0.00%
+100.0%
Q3 2022$1,115,000
+378.5%
41,253
+144.7%
0.00%
Q2 2022$233,000
-90.3%
16,858
-86.2%
0.00%
-100.0%
Q1 2022$2,391,000
+147.5%
122,598
+99.8%
0.01%0.0%
Q1 2019$966,00061,3500.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders